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Abstract
Background: Metabolic engineering is an attractive approach in order to improve the microbial production of drugs.
Triterpenes is a chemically diverse class of compounds and many among them are of interest from a human health
perspective. A systematic experimental or computational survey of all feasible gene modifications to determine the
genotype yielding the optimal triterpene production phenotype is a laborious and time-consuming process.
Methodology/Principal Findings: Based on the recent genome-wide sequencing of Saccharomyces cerevisiae CEN.PK 113-
7D and its phenotypic differences with the S288C strain, we implemented a strategy for the construction of a b-amyrin
production platform. The genes Erg8, Erg9 and HFA1 contained non-silent SNPs that were computationally analyzed to
evaluate the changes that cause in the respective protein structures. Subsequently, Erg8, Erg9 and HFA1 were correlated
with the increased levels of ergosterol and fatty acids in CEN.PK 113-7D and single, double, and triple gene over-expression
strains were constructed.
Conclusions: The six out of seven gene over-expression constructs had a considerable impact on both ergosterol and b-
amyrin production. In the case of b-amyrin formation the triple over-expression construct exhibited a nearly 500% increase
over the control strain making our metabolic engineering strategy the most successful design of triterpene microbial
producers.
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Introduction
Metabolic engineering, which integrates engineering design
with systematic and quantitative analysis of metabolic pathways, is
considered as one of the major concepts in biotechnology [1]. The
central goal of metabolic engineering is the optimization of the
metabolic phenotype with an emphasis on the global state of the
cell, and not the individual reactions [2]. This manipulation of the
system with consideration of the efficiency of the overall bioprocess
is what distinguishes metabolic engineering from genetic engi-
neering [3]. Well-characterized and genetically fairly easy to
manipulate heterologous hosts, like Escherichia coli and Saccharomyces
cerevisiae, allow very specific engineering of biosynthetic pathways
for increased yields and generation of novel compounds. After
engineering a pathway, it is desirable to analyze the metabolic
profile to be able to compare before and after situations and detect
effects on the pathway originating from distant networks [4].
Metabolic engineering of microorganisms through the expres-
sion of one or more plant genes, often in connection with genetic
alteration of the whole cell metabolism, has become an
increasingly important route for small molecule synthesis.
Terpenoids, with more than 55,000 members identified, have
particularly benefited from this approach [5]. The value of these
natural products extends beyond their biological utility and they
have been commercialized to serve as antibiotics, anticancer and
other medicinal products. The need for metabolic engineering as a
framework of terpenoid production has arisen mainly as a result of
supply issues, since these molecules are synthesized in only minute
amounts in the natural hosts hampering their commercialization.
Engineering of plant terpenoids into microbial hosts has been
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focused primarily on isoprenoid-derived compounds such as
carotenoids, artemisin, and paclitaxel [6-8].
Metabolic pathways are stamped by natural bottlenecks, which
serve as control points within a native organism, to regulate
resource utilization and production of metabolites. The ultimate
goal of metabolic engineering is to predict the engineering
required for increasing (or maximizing) a metabolic flux through
a desired pathway, however, this has been particularly challenging
[9]. The lack of extensive knowledge about molecular interactions
and their kinetics makes the dissection and optimization of
metabolic pathways an outstanding issue of central importance
[10]. The identification of distant genes affecting a metabolic
phenotype, either through redistribution of metabolic precursors
or indirect kinetic and global regulatory effects recently spurred by
the high-throughput ‘omics’ and genome-based bioinformatic
approaches. Here we describe a novel method for pathway
optimization that focuses on identifying rate-limiting enzymes. We
establish a proof-of-concept that whole genome sequencing can be
used to identify single nucleotide polymorphisms between S.
cerevisiae strains, which can be subsequently linked with particular
phenotypes of interest (Figure 1). For example Daum et al [11]
have observed that the content of ergosterol and fatty acids in
CEN.PK is significantly higher than other yeast strains indicating
a possible correlation between genotype and phenotype. Previ-
ously to our work, a total of 13,787 high-quality SNPs, of which
782 in metabolic genes [12], were detected when the CEN.PK
113-7D sequence was compared to the S288C, the reference
genome of the Saccharomyces Genome Database. In the genomic
comparisons of the two strains by Otero et al the ergosterol
biosynthetic pathway had several non-silent SNPs identified in
Erg8 and Erg9, and silent SNPs identified in Erg20 and HMG1 [12].
In their paper the authors performed also a transcriptome
comparison between the two yeast strains. Both Erg8 and Erg9
were not significantly differentially expressed in glucose suggesting
that their potential affect on phenotype is likely post-transational.
Amino acid substitutions resulting from SNPs can enhance the
properties of a protein such as stability or catalytic activity and are
essential raw material of evolution [13]. They are starting points
for the adaptive evolution of new functions and often occur
through pathways consisting of sequential beneficial mutations
[14]. The effect of mutations on stability (DDG) of proteins has
been explored by several researchers [15-17]. It has been shown
that mutated proteins that are more stable than a particular
threshold energy can fold properly and result in improved or
changed function [18-21]. Changes in inter-residue interactions
caused by mutations are also important for understanding protein
folding and stability patterns of proteins [22].
The current work was undertaken to develop S. cerevisiae as a
production platform of triterpenoids using direct correlations
between genotype and phenotype. We describe here the utilization
of detected metabolic SNPs for constructing 7 yeast mutants
engineered to enhance carbon flux through the mevalonate
pathway and accumulate high levels of b-amyrin (Figure 1). Such
developments support long range objectives to generate large
quantities of end-product triterpenoids sufficient for detailed
chemical analyses and diverse biological and industrial testing.
Results
SNPs role on Erg8, Erg9 and HFA1
In their paper on the genome wide sequencing of CEN.PK113-
7D, Otero et al [12] identified two pathways with a significant
number of SNPs (Figure 1), both silent (blue font) and non-silent
(red font). Erg8 and Erg9, both participating in the ergosterol
biosynthesis pathway, included in total 7 silent and 5 non-silent
SNPs. In Erg8 there were detected 4 non silent SNPs in positions
49, 75, 192, and 247, while in Erg9 there was only 1 non silent
SNP in position 286 (Figure 1). In fatty acid metabolism, the HFA1
gene was highly enriched with 20 silent and non-silent SNPs.
HFA1 contained non-silent SNPs in amino acid positions 579, 877,
971, 1056, 1273, and 1798.
Predicting the effects of the nsSNPs on the protein structure-
stability-function of Erg8, Erg9 and HFA1 is very important for
selecting the three genes as metabolic engineering targets. The
computational strategy shown in Figure 2 was employed in the
present study, however our findings should be evaluated with
caution since no experimental verification was obtained for the
three last steps of the flowchart.
Computational analysis of nsSNPs based on primary
amino acid sequence
The underlying principle of the SIFT algorithm is that it
generates alignments with a large number of homologous
sequences and assign a tolerance index score to each amino acid
substitution ranging from 0 to 1 [23]. The higher the tolerance
index of a mutant is, the less functional impact the respective
amino acid substitution is likely to have. The results of SIFT for
respective amino substitutions in Erg8, Erg9 and HFA1 sequences
are shown in Supporting Information S1. The results were
examined by considering the S. cerevisiae S288C as the ‘‘wild type
strain’’ and the CEN.PK113-7D as the ‘‘mutant strain’’ in the first
step, and vice versa. From the SIFT scores, it appears that the
nsSNPs of Erg8 and HFA1 have an overall effect on CEN.PK113-
7D, whereas, the nsSNP of Erg9 has a neutral effect. This
assessment of nsSNPs by SIFT is mainly based on the conserved
positions along the amino acid sequences, and to understand the
effect of nsSNPs on inter-residue interactions and protein stability,
structural analysis is a necessity.
Protein stability estimation in coding nsSNPs based on
3D structures
Sequence and secondary structure alignments of phosphome-
valonate kinase (the protein product of Erg8) against the protein
models by PMP resulted into the selection of the Lin0012 protein
from Listeria innocua (DOI:10.2210/pdb3k17/pdb) as a template
for homology modeling. The secondary structure alignments and
respective scores generated using ClustalW [24] are shown in
Supporting Information S1. Pairwise structural alignment of the
3k17C and the Erg8 protein product was employed using the Dali
server [25] and is shown in File S1. The 3D-structural similarity
information of the Lin0012 protein from Listeria innocua (PDB ID:
3k17) with the existing crystal structures was retrieved from the
Research Collaboratory for Structural Bioinformatics – Protein
Data Bank [26] that uses the FATCAT method for flexible
structural alignments of proteins. The information shown in
Supporting Information S1 depicts the similarity of Lin0012
protein from Listeria innocua with kinase enzymes. The homology
model validation (Supporting Information S1) of the Erg8 protein
products from S. cerevisiae S288C and CEN.PK113-7D using the
ProSA-web showed z-scores of -6.1 and -5.97, respectively. The z-
scores of homology models for both Erg8 protein products are in
the range characteristic for x-ray determined structures deposited
in Protein Data Bank.
The homology modeling and structure validation of the Erg9
protein products from S. cerevisiae S288C and CEN.PK113-7D was
performed as above. Sequence and secondary structure alignments
for squalene synthase against the protein models by PMP resulted
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Figure 1. Schematic illustration of the mevalonate, the sterol pathway and the initial step of the fatty acid biosynthetic process, as
well as the steps engineered in the current study for triterpene production in yeast. The mevalonate pathway is localized to the
cytoplasm of eukaryotic cells and supports the biosynthesis of numerous terpenoids using different precursor molecules, while ergosterol is the
dominant terpenoid. Whole genome Illumina-Solexa sequencing of CEN.PK113-7D and S288C was completed prior to our study, and SNPs strictly
related to metabolic genes were identified [12]. There were clear correlations between physiology and pathway enrichment of non-silent SNPs
observed in genes involved in the ergosterol biosynthesis (red font indicates non-silent SNPs, while blue font indicates silent ones), suggesting that
genome-sequencing may assist in reducing the genetic target space for metabolic engineering applications. Various combinations of over-
expressions (single, double, triple) of genes coding for phosphomevalonate kinase (Erg8), squalene synthase (Erg9), and acetyl-coenzyme A
carboxylase (HFA1) may yield yeast strains capable of accumulating excess levels of b-amyrin, a triterpene molecule originating from oxidosqualene.
doi:10.1371/journal.pone.0014763.g001
Figure 2. Strategy for computational analysis of the non-silent (ns)SNPs.
doi:10.1371/journal.pone.0014763.g002
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into the selection of a human squalene synthase [27] as a template.
The secondary structure alignments and respective scores
generated using ClustalW [24] are also shown in Supporting
Information S1. Pairwise structural alignment of the 1ezfC and the
Erg9 protein product was employed using the Dali server [25] and
it is shown in Supporting Information S1. The homology model
validation (Supporting Information S1) of the Erg9 protein
products from S. cerevisiae S288C and CEN.PK113-7D using the
ProSA-web showed z-scores of -7.88 and -7.85, respectively.
Yeast contains two distinct acetyl-CoA carboxylase multi-
component enzyme systems, one in the cytoplasm encoded by
ACC1, and another one in the mitochondrial matrix encoded by
HFA1 [28]. The HFA1 protein product consists of three functional
units (Supporting Information S1), biotin carboxylase, biotinoyl
domain or biotin-carboxyl-carrier protein and carboxyl transferase
[29]. The homology models of the HFA1 protein product catalytic
domains were built using MODWEB, which is based on
MODPIPE, an automated software pipeline for comparative
modeling [30-31]. The modelled segments of the HFA1 protein
and the respective templates used for homology modeling are shown
in Supporting Information S1. Out of six nsSNPs, only one nsSNP
leading to amino acid substitution (I1798T) fall in a catalytic domain
of the HFA1 protein product, i.e., carboxyl transferase domain.
Therefore, the carboxyl transferase domain was considered for
further analysis. The homology model validation (Supporting
Information S1) for the carboxyl tranferse domain of the HFA1
protein products from S. cerevisiae S288C and CEN.PK113-7D using
ProSA-web showed z-scores of -8.51 and -8.53, respectively.
The change in the protein stability (DDG) induced by mutations
calculated by the Eris server indicated that Erg8, Erg 9 and HFA1
protein products from S. cerevisiae CEN.PK113-7D were probably
more stable than that from S288C (Supporting Information S2).
Accessible Surface Area calculations for the Erg8, Erg9 and HFA1
proteins and respective energies calculated by the InterProPatch
server (Supporting Information S2) also strengthen the protein
stability predictions obtained from Eris.
Graph theoretic measures of structural effects in proteins
caused by individual nsSNPs
Bongo calculates the overall impact (I) of a mutation according to
the ‘key’ residues affected by the mutation [32]. To understand the
notation of ‘key’ residues, let’s consider the amino acid substitutions
of the Erg8 protein product. Comparison of residue-residue
interaction graphs (Supporting Information S2) clearly shows that
amino acid substitutions viz., G49E, S75T and D247N have no
change in local environment of interactions with other residues,
whereas A129S amino acid substitution changes both local and
global residue-residue interaction networks. Analysis of the effect of
individual nsSNPs by Bongo shows that G49E, S75T and D247N
amino acid substitutions have an overall impact value within the
threshold (I,1), whereas A129S amino acid substitution shows an
impact value greater than 1 (I.1) and therefore may cause
structural effects on the Erg8 protein product. A protein can tolerate
functionally beneficial but destabilizing substitutions, only if it has
previously acquired one or more stabilizing mutations [33]. In the
case of the Erg9 protein product, the nsSNP or amino acid
substitution G286S appears to have no effect on local or global
residue-residue interaction networks (Supporting Information S2).
RMSD differences between protein variants and analysis
of binding pockets
Structural superposition of the Erg8, Erg9 and HFA1 protein
product variants was done using the SuperPose. The RMSD
differences of alpha carbons, protein backbone, heavy atoms and
overall RMSD between the variants of Erg8, Erg9 and HFA1
protein products are shown in SupportingInformation S2. An
overall RMSD of 2.02 A˚ was observed between the 3D-structures
of the Erg8 protein product from S. cerevisiae S288C and
CEN.PK113-7D. No RMSD differences were observed between
the Erg9 protein product variants, indicating that the nsSNP
acquired by CEN.PK113-7D has probably no effect on the 3D
structure which is in line with the residue-residue interaction
network analysis discussed above. The HFA1 protein product
variants showed an overall RMSD of 1.63 A˚ between their 3D-
structures.
Analysis of the hinge regions using the H-predictor server also
showed no differences in the case of the Erg9 protein product
variants, whereas a few differences were observed for the variants
of Erg8 and HFA1 protein products (Figure 3). It should be noted
that the predictions from the H-predictor server are not a measure
of the protein’s propensity for domain-swapping, but rather a
structural propensity that a hinge region may result in domain
swapping and also provide hint to the weakest regions that unfold
prior to the compete unfolding of protein.
Ligand binding sites of phosphomevalonate kinase,
squalene synthase and carboxyl transferase domain
Phosphomevalonate kinase catalyzes the phosphorylation of
mevalonate-5-phosphate into mevalonate-5-pyrophosphate [34].
The template 3k17 (Lin0012 protein from Listeria innocua) that used
for homology modeling of the Erg8 protein products of S. cerevisiae
S288C and CEN.PK113-7D showed high sequence and structural
similarity with the crystal structure of phosphomevalonate kinase
(3GON) from Streptococcus pneumoniae. The active site of the
phosphomevalonate kinase (3GON) has been showed to have
enough space to accommodate interconversion of the reactive and
the nonreactive conformers [35]. The crystal structure of the
ternary complex of phosphomevalonate kinase with phosphome-
valonate and adenosine 59-[b,c-imido]triphosphate (AMPPNP)
showed the presence of twenty-one ordered water molecules filling
the interstices between the van der Waals surfaces of the
phosphomevalonate kinase active site and its ligands. We analyzed
the indirect binding pattern of amino acid residues with the ligands
through clusters of ordered water molecules in the active site of
phosphomevalonate kinase (Figure 4). A significant fraction of
reactive regions is filled with a shell of water molecules, raising the
issue about how phosphomevalonate kinase active site manages to
prevent b,c-bond hydrolysis during its catalytic cycle [35]. Analysis
of the binding pockets in phosphomevalonate kinase from S.
cerevisiae S288C and CEN.PK113-7D using Q-SiteFinder guided
us to assume that nsSNPs acquired by CEN.PK113-7D strain
were able to decrease the void space of the binding pocket which
we consider as nature’s engineering (Figure 5).
Squalene synthase is a membrane associated bifunctional
enzyme that catalyzes the condensation of two molecules of
farnesyl diphosphate (FPP) to give presqualene diphosphate (PSPP)
and the subsequent rearrangement of PSPP to squalene [36]. In
the human squalene synthase (PDB ID: 1ezf) it has been found
that the five a helices surrounding the active center are structurally
similar to that of other isoprenoid biosynthetic enzymes viz.,
farnesyl-diphosphate synthase, pentalenene synthase and 5-epi-
aristolochene synthase [27]. When the crustal structures of these
four enzymes were superimposed by Pandit et al [27], they all
showed exactly the same orientation and interestingly less than
16% of the residues are identical in the superimposed parts,
indicating that the pattern of the catalytic core is highly conserved
structurally. It has also been suggested that all class-I isoprenoid
Triterpenoid Yeast Factory
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Figure 3. Identifying the hot-spot hinge regions of domain swapping in the variants of the Erg8, Erg9 and HFA1 protein products.
doi:10.1371/journal.pone.0014763.g003
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enzymes may have evolved with similar structures regardless of the
degree of amino acid sequence identity [37]. Based on these
observations we expected that a single nsSNP coding for an amino
acid substitution distant from catalytic core may have less
structural impact on squalene synthase. Analysis of the binding
pockets in homology models of squalene synthase from S. cerevisiae
S288C and CEN.PK113-7D using Q-SiteFinder provided some
evidence that the binding pockets of both Erg9 protein products
are similar (Supporting Information S3).
Biotin carboxylase domain catalyzes the ATP dependent
carboxylation of a biotin group covalently linked to biotin
carboxyl carrier protein, and then the carboxyl transferase domain
catalyzes the transfer of the carboxyl group from biotin to acetyl-
CoA to produce malonyl-CoA [28]. The amino acid sequences of
carboxyl transferase domains have been found to be highly
conserved among the eukaryotic multifunctional acetyl-CoA
carboxylases and Zhang et al [38] have determined the crystal
structure of the yeast carboxyl transferase domain in complex with
CoA (PDB ID: 1OD2). Q-SiteFinder has been limited to PDB files
with less than 10,000 atoms and was not able to predict the
binding sites in the carboxyl transferase domain. So we used the
CASTp server, an online tool that locates and measures pockets
and voids on 3D protein structures [39]. However, CASTp was
not able to correctly predict the location of the binding site in the
carboxyl transferase domain where CoA molecule is known to
bind [38]. We therefore superimposed the homology model
structures of the HFA1 protein products (CT domain) from S.
cerevisiae S288C and CEN.PK113-7D using the Swiss-Pdb Viewer
tool [40], to observe the structural effect of the nsSNP acquired by
the CEN.PK113-7D strain (Supporting Information S3). We
observed a few changes in the loops around the cavity where the
CoA molecule is known to bind with the carboxyl transferase
domain.
Effects on ergosterol content and growth rate
Single over-expression constructs. In order to test our
hypothesis of a possible connection between the high levels of
ergosterol in the CEN.PK strain and the proteins Erg8, Erg9 and
HFA1, the corresponding three genes were over-expressed
resulting to the strains 1026.bA, 1027.bA and 1029.bA,
respectively (Figure 6). The three strains harbour also the PSY
gene, however, the gene was under the control of the GAL1
promoter and no b-amyrin is produced during the glucose phase.
This design allowed us to discern the effect of the over-expressions
on the ergosterol content when there is no competition between
the sterol pathway and the production of terpenes and on the
Figure 4. Ligand interaction diagrams for the active site of the phosphomevalonate kinase (PDB ID: 3GON). It was calculated that only
50% of the charge moieties of the ligands were in van der Waals contact with the protein. (a) The active site residues of phosphomevalonate kinase
and their interaction with the ligands phosphomevalonate and AMPPNP through clusters of ordered water. Ligands are shown in ball and stick
model. Phosphomevalonate is shown in brown color and AMPPNP in magenta color. Hydrogen bonds are shown as blue dashed lines. (b) Ligand
binding pattern for AMPPNP and distance between the interacting amino acid residues calculated using the Accelry Discovery Studio version 2.5. (c)
Ligand binding pattern for phosphomevalonate calculated and distance between the interacting amino acid residues using the Accelrys Discovery
Studio version 2.5. The values shown are in A˚ units.
doi:10.1371/journal.pone.0014763.g004
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second phase of the cultivation (ethanol consumption) to actually
monitor the flux redirection among the two pathways for the
available precursor (oxidosqualene). Indeed during our cultivations
and until glucose was exhausted there was no b-amyrin production
detected. On the other hand, the ergosterol content was
significantly affected from the over-expressions when the
constructs were compared with the control strain 1023.bA
(Figure 7). The yield of ergosterol per gram of DW at the end of
the exponential phase was ,1.6-fold higher in the strains 1027.bA
and 1029.bA compared to the 8.1 mg of ergosterol/g of DW that
was determined for the control strain. In addition the specific
growth rate of 1027.bA and 1029.bA was 14% and 9% lower than
the reference strain (CEN.PK-5D), while the difference between
the 1023.bA and the reference strain was negligible (3%).
However, the most promising strain appeared to be 1026.bA,
which reached an ergosterol content of 17.7 mg/g of DW, with no
effect on the specific growth rate that remained unaltered
compared to the reference strain.
Double and triple over-expression constructs..
Optimization of a secondary metabolite phenotype, such as
ergosterol production, obviously depends on the modulation of
several genes. With the intention to test a possible synergy in the
resulting phenotype between the Erg8, Erg9 and HFA1 genes, the
three double over-expression strains were also constructed.
Figure 7 summarizes the results of the multiple gene over-
expression constructs which seem to be of considerable interest.
The three combinations resulted in the strains 1028.bA, 1030.bA
and 1057.bA, which outperformed in ergosterol level the single
over-expression constructs. The observed higher ergosterol levels
of the double over-expression constructs it was not surprising and
it could be predicted since the single over-expressions either
enhanced (Erg8, HFA1) or matched (Erg9) the ergosterol level of
the control strain. While a combination of Erg8 and Erg9 (1028.bA)
had moderate effects on the ergosterol yield compared to the effect
of the Erg8 alone (1026.bA), this was not the case for the other two
strains. The 1057.bA (Erg8, HFA1) strain reached an ergosterol
level of 30 mg/g of DW, while even more impressive was the 34.3
mg of ergosterol/g of DW for the 1030.bA (Erg9, HFA1) strain. At
the same time the specific growth rate of the 1030.bA appeared to
be less affected by the over-expressions (,14% decrease)
compared to the other two strains which presented an .25%
decrease on their growth rate (Figure 7). The presence of multiple
plasmids within the yeast cell can be responsible for this profound
impact on the cellular physiology since they often impose a
metabolic burden on the cell. The highest ergosterol content was
observed when the Erg8, Erg9 and HFA1 genes were
simultaneously over-expressed. The quantification of the
ergosterol content for the strain named 1031.bA revealed an
amount as high as 46 mg/g DW, while the specific growth rate
was not lower than the double constructs 1028.bA, and 1057.bA.
b-amyrin production
Single over-expressions. In the second phase of the
cultivation, and while all glucose had been consumed, the
Figure 5. Ligand binding sites predicted using Q-SiteFinder. The two top ranked binding pockets were selected in each case. The differences
between the phosphomevalonate kinase from S. cerevisiae S288C and CEN.PK113-7D strains can be clearly observed from the homology model
structures shown. (a) Q-SiteFinder predictions for binding pockets in the phosphomevalonate kinase from Streptococcus pneumoniae, for which
crystal structure data is available (PDB ID: 3GON). Q-SiteFinder was able to accurately predict the active site of 3GON with two binding pockets, one
each for phosphomevalonate and AMPPNP. Both ligands are represented in stick model. (b) Q-SiteFinder predictions for binding pockets in
phosphomevalonate kinase from S. cerevisiae S288C. (c) Q-SiteFinder predictions for binding pockets in phosphomevalonate kinase from S. cerevisiae
CEN.PK113-7D.
doi:10.1371/journal.pone.0014763.g005
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growth of the constructs was based on the ethanol consumption.
During that period the production of b-amyrin was observed and
the effect of the over-expression of Erg8, Erg9, and HFA1 was
evaluated. The strain 1023.bA was harbouring only the b-amyrin
synthase gene and no other modification for higher expression was
applied. Our metabolic engineering strategy was assessed based on
the production level of this control strain. After a total cultivation
time of 48 h the 1023.bA reached a maximum value of b-amyrin
of 0.69 mg/L (Figure 8). In the strain 1027.bA, despite the fact
that the over-expression of Erg9 led to increased ergosterol yield in
the glucose phase compared to the control strain, this positive
effect was not reflected in the b-amyrin production levels during
the ethanol phase (Figure 8). The final b-amyrin concentration
was 0.66 mg/L while the ergosterol yield was 11 mg/g of DW,
slightly lower than the 11.5 mg/g of DW of the control strain (data
of ergosterol in the ethanol phase not shown). On the other hand
over-expression of HFA1 and Erg8 did enhance the strains capacity
to produce b-amyrin. As shown in Figure 8 after 48 h the strain
1029.bA produced 0.82 mg/L of b-amyrin. A further increase in
the production levels was obtained from the strain 1026.bA with
over 1.6-fold improvement compared to the control strain. The
1.17 mg/L of b-amyrin for 1026.bA was accompanied with an
ergosterol yield of 12 mg/g of DW, higher than the control strain
and the 1029.bA (8.9 mg of ergosterol/g of DW).
Double and triple over-expressions. We further monitor
the b-amyrin changes triggered by the simultaneous up-regulation
of the Erg8, Erg9, and HFA1 genes in all the different combinations
and the results are summarized in Figure 8. Surprisingly, even
though Erg9 over-expression had no marked impact on the b-
amyrin measured, in combination with Erg8 and HFA1 over-
expression the production was positively altered. The strain
1030.bA (Erg9, HFA1) produced 1.05 mg/L of b-amyrin, a 59%
and 28% increase compared to the 1027.bA (Erg9) and 1029.bA
(HFA1) respectively, having single over-expressions. The ergosterol
yield of the 1030.bA was also rather high (25.7 mg/g of DW) but
as in the case of the single over-expressions lower than the
observed yield on glucose phase (34.3 mg/g of DW). On the other
hand, the change in the b-amyrin observed for 1028.bA (Erg8,
Erg9) was significantly greater than the 59% increase seen in the
1030.bA. The 1028.bA can accumulate up to 1.68 mg/L of b-
amyrin, a 154% increase compared to the 1027.bA (Erg9) but only
43% increase compared to the 1026.bA (Erg8). The ergosterol
yield for the strain 1028.bA was 31.3 mg/g of DW. However, from
all the double over-expression constructs the combination of Erg8
and HFA1 (1057.bA) was the most attractive. The difference in the
b-amyrin levels between the 1057.bA and the control strain
appear to be over twice the difference than the best single over-
expression achieved (1026.bA). The 2.39 mg/L of b-amyrin that
1057.bA produced were an increase of 246% compared to the
control strain, while maintaining the high ergosterol levels
(34 mg/g of DW). The construct with the triple over-expression
of Erg8, Erg9, and HFA1 outperformed the production of all the
Figure 6. Systematic gene over-expression in CEN.PK strains harbouring a plasmid (pYES: GAL1 promoter/URA3 selection marker)
with the PSY gene (P. sativum) coding for a b-amyrin synthase. The three genes Erg8, Erg9, and HFA1 were ligated in different plasmids with
the HIS3, TRP1 and LEU2 selection markers respectively, using the TDH3p promoter, and they were transformed in all combinations (single, double,
triple over-expressions) to the respective parental strains leading to prototrophic strains. A visual representation of the final constructs containing
from one (1) up to four (4) plasmids, as well as the name of the resulting strains, which is used in the text, is also given.
doi:10.1371/journal.pone.0014763.g006
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single and double over-expression constructs by a great extend.
The final concentration of b-amyrin from the 1031.bA strain
represents an increase of almost 500% compared to the control
strain. The 3.93 mg/L of b-amyrin for the 1031.bA was a 3.4-
times more b-amyrin than the best single over-expression
construct (1026.bA) and 1.6-times more than the best double
over-expression construct (1057.bA). At the same time the
ergosterol content of the 1031.bA was higher than during the
glucose phase and the highest observed compared to all the other
strains (69.6 mg/g of DW).
Discussion
Triterpenoids are a large class of isoprenoidal natural products
present in higher plants. Among them, oleanane type triterpenes,
which are produced from b-amyrin, are one of the most common
Figure 7. Physiological characterization of the reference and recombinant S. cerevisiae strains. (A) Bars represent the growth rates of
the constructs relative to the reference strain when grown on glucose and the inset shows the growth curves. (B) Improved in vivo production of
ergosterol from CEN.PK constructs. The production yields have been calculated at the end of the exponential growth. During this time period no b-
amyrin was detected. Strains: PSY (1023.bA), Erg8,PSY (1026.bA), Erg9,PSY (1027.bA), HFA1,PSY (1029.bA), Erg8,Erg9,PSY (1028.bA), Erg9,HFA1,PSY
(1030.bA), Erg8,HFA1,PSY (1057.bA), Erg8,Erg9,HFA1,PSY (1031.bA).
doi:10.1371/journal.pone.0014763.g007
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triterpenes, along with ursane type triterpenes produced from a-
amyrin. b-amyrin in particular serves as the olefin precursor to a
wide range of downstream products. The action of oxidative
enzymes and glycosyltransferases convert b-amyrin to various
triterpene saponins. These saponins exhibit a wide range of both
structural diversity and biological activity (antimicrobial, insecti-
cidal agents) and therefore are regarded as important and
promising sources for medicinal compounds. The effect of plant
saponins on low-density lipoprotein cholesterol absorption and
arterial atherosclerosis has received much attention, leading to the
development of several cholesterol-reducing dietary supplements
[41]. The formation of these complex carbon skeletons through a
series of protonation, cyclization, rearrangement and deprotona-
tion reactions of 2,3-oxidosqualene is well documented in the
famous biogenetic isoprene rule [42]. Although triterpene
synthases have been expressed in microbial hosts such as S.
cerevisiae there has been little effort made so far to engineer the
metabolism of a microbial host for enhanced production of
triterpenes. Imbalances in gene expression can lead to –over or –
under production of enzymes in the pathway, accumulation of
toxic metabolic intermediates, and metabolic burden on the host,
all of which result in suboptimal product titers [43]. A novel
metabolic engineering strategy for designing a triterpenoid-yeast-
production-platform is presented here based on the whole genome
sequencing of S. cerevisiae CEN.PK recently completed by Otero
et al [12].
The non-synonymous SNPs, the so called non-silent SNPs,
which are single nucleotide variations in the coding regions that
gives ‘birth’ to amino acid mutations, are often involved in the
modulation of protein function. Understanding the effect of
individual amino acid mutations on a protein/enzyme function or
stability is useful for altering its properties for wide variety of
engineering studies. Since measuring the effects of mutations
experimentally is a laborious process, a variety of computational
methods and algorithms have been devised to predict these effects
in silico [44-50]. Bioinformatics approaches to predict the effect of
mutations on protein stability utilizes the sequence alignment
information of evolutionarily related sequences [51] or protein
families or rely on physicochemical modeling of the mutation
augmented by information obtained from statistical analyses of
protein sequences and three-dimensional structures [52]. Compu-
tational approaches for predicting the effect of amino acid
mutations has proven to be surprisingly successful, with a wide
range of studies supporting them [53-56]. Different computational
algorithms provide valuable insights to explore relationships
between beneficial mutations and phenotypic variation and speed
up both fundamental and industrial applied research [57]. Erg8,
Erg9, and HFA1 genes are part of the sterol and fatty acid
biosynthesis in S. cerevisiae. S. cerevisiae CEN.PK contains an
unusually high content of ergosterol and fatty acids compared to
other S. cerevisiae strains [11]. When Otero and colleagues [12]
compared the genome-wide sequence of CEN.PK with S288C
Figure 8. Production of b-amyrin is shown over 48 h for the constructs with single, double and triple over-expressions of Erg8, Erg9,
and HFA1, and the control strain. The b-amyrin was detected after the exhaustion of glucose and the initiation of the consumption of ethanol
that had produced by the strains. The data shown as total production are means for two independent cultivations for each strain.
doi:10.1371/journal.pone.0014763.g008
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they identified a number of SNPs in these 3 genes. Our hypothesis
in this study was that these SNPs are linked to the observed
phenotype in CEN.PK, by the formation of more efficient Erg8,
Erg9 and HFA1 proteins, influencing the flux towards the two
pathways. Our hypothesis was supported by the use of an array of
computational tools that there is a positive effect of the nsSNPs on
the protein structure-stability-function of the Erg8, Erg9 and
HFA1.
The Erg8 codes for a phosphomevalonate kinase, an essential
cytosolic enzyme which catalyzes the reaction ATP+(R)-5-
phosphomevalonate = ADP+(R)-5-diphosphomevalonate. An indi-
rect over-expression of Erg8 through an enhanced activity of
UPC2 (a global transcription factor regulating the biosynthesis of
sterols in S. cerevisiae) for terpenes production has been studied by
Ro et al [58]. However, UPC2 as a single modification had only a
modest effect on amorphadiene production. A negative effect of
the enhanced UPC2 activity on the epicedrol production, a
sesquiterpene originating from FPP, was observed by Jackson et al
[59]. However, in the present study the direct over-expression of
Erg8 resulted in higher ergosterol content than the control strain
during growth on glucose, which was then reflected in the ethanol
phase in the 1.6-fold higher production of b-amyrin compared to
the control strain.
The Erg9 codes for a squalene synthase that joins two farnesyl
pyrophosphate moieties in the reaction 2 farnesyl diphosphate =
diphosphate+presqualene diphosphate. There have been several
studies targeting Erg9 as an attempt to increase precursor
availability for terpenes production. In the case of Shimada et al
[60] disruption of the Erg9 gene as a single modification in Candida
utilis had no significant effect on lycopene production. On the
other hand Paradise et al [61] increased by 5-fold the production of
amorphadiene by down-regulating the Erg9, however this
improvement was in a strain background with several other
genetic modifications. In line with the above two studies were the
effects of Erg9 over-expression in the b-amyrin production
observed here. While Erg9 over-expression as a single metabolic
engineering strategy had no positive effect on b-amyrin produc-
tion, in combination with Erg8 over-expression there was a 2.4-fold
improvement compared to the control strain.
The HFA1 is a mitochondrial acetyl-coenzyme A carboxylase that
catalyzes the production of malonyl-CoA in fatty acid biosynthesis
through the reaction ATP+acetyl-CoA+HCO3 2= ADP+phospha-
te+malonyl-CoA. Interestingly, by enhancing the expression level of
HFA1 the production level of b-amyrin was improved by 1.2 times.
Kizer et al [62] engineered an E. coli strain to produce high levels of
terpenoids, however, further optimization led to an imbalance in
carbon flux and the accumulation of the pathway intermediate 3-
hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA), which proved
to be toxic to E. coli. Their results indicated that HMG-CoA inhibits
fatty acid biosynthesis in the microbial host, leading to generalized
membrane stress. The cytotoxic effects of HMG-CoA accumulation
could be counteracted by the addition of palmitic acid and oleic acid,
and it is possible that the positive effect of HFA1 over-expression in
ergosterol and b-amyrin levels that we observed in our study to be a
mechanism of the cell to deal with the high HMG-CoA
concentrations. Over-expression of HFA1 with concomitant over-
expression of Erg8 led to the highest production of b-amyrin in
between all the single and double over-expression constructs, while
the final concentration was 3.5-fold higher than the control strain.
Further improvement in the b-amyrin production level was achieved
by the triple over-expression construct.
In summary we have created a strain of S. cerevisiae capable of
producing 500% more b-amyrin than the control strain by the
simultaneous over-expression of Erg8, Erg9 and HFA1. To the best
of our knowledge the only metabolic engineering work applied for
b-amyrin production has been performed by Kirby et al [63]. By
manipulating the two key enzymes in the pathway, HMG-CoA
reductase and lanosterol synthase, Kirby and colleagues improved
the b-amyrin production by 50%. This was a 10-fold lower
improvement than the one achieved through our metabolic
engineering strategy. However, in the study of Kirby et al the final
titer of b-amyrin was 6 mg/L [63].
In addition to the above modifications, a careful inspection of
the metabolic pathways that include the acetyl-CoA molecule for
SNPs could reveal more targets for redirecting the fluxes towards
the mevalonate pathway. The supply of acetyl-CoA has been
shown as an important parameter for the production of many
secondary metabolites and in particular terpenoid molecules, as
Shiba et al [64] demonstrated in their study.
However, it is important also to stress out that despite the very
encouraging results from integrating protein computational
analysis with metabolic engineering, there is a clear need for
further experimental verification of our hypothesis. In order to
increase our confidence that the SNPs in the three proteins are
responsible for the differences observed in the ergosterol level
between the strains, we should create point mutations in the
CEN.PK genes to construct the respective version of the S288
strain and examine if the phenotype of S288 is restored in the
CEN.PK and vice versa. This could potentially demonstrate the
role of the SNPs in a flux level. Additionally, an isolation of the
different versions of the S288 and CEN.PK proteins and the
evaluation of their in vitro activity against their natural substrates
would definitely strengthen the computational predictions regard-
ing the beneficial effects caused by the SNPs in the proteins of
CEN.PK. It would also be of interest to overexpress Erg8, Erg9 and
HFA1 in S288 and compare the obtained levels of b-amyrin in
S288 and CEN.PK which may point out other limitations in
creating a yeast b-amyrin hyper-producer.
In this work we propose that high-throughput genome
sequencing of S. cerevisiae may serve as a commonplace tool,
complimentary to transcriptomics and physiological characteriza-
tion, to extract direct genotype to phenotype information. The
analysis presented here serves as a foundation for comparative
metabolic engineering SNP analysis, where in the future reference
strains may be compared to their metabolically engineered
derivatives that use directed evolution in order to answer what
changes have made a strain a preferred microbial cell factory.
Future work must also expand to the SNP analysis presented in the
paper of Otero et al [12] to include all 13,787 SNPs, realizing
phenotypic observations may not necessarily be linked directly to
metabolic SNPs, but rather SNPs affecting larger regulatory
mechanisms and networks, such as those governed by transcrip-
tion factors.
Materials and Methods
Analysis of nsSNPs by Sequence Homology Based
method
We used SIFT, a sequence homology based tool that Sorts
Intolerant From Tolerant amino acid substitutions, to find out the
effect of nsSNPs in Erg8, Erg9 and HFA1 protein products. The
SIFT algorithm relies solely on sequence to predict whether an
amino acid substitution at a particular position in a protein will
have a phenotypic effect. To predict the effect of an amino acid
substitution, SIFT considers the information about the position at
which the change occurred and the type of amino acid change.
SIFT is a multistep procedure that, for a query sequence, (1)
searches for similar sequences, (2) chooses closely related
Triterpenoid Yeast Factory
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sequences that may share similar function, (3) obtain multiple
alignment of these chosen sequences, and (4) calculates normalized
probabilities for all possible substitutions at each position from the
alignment. Substitutions at each position with normalized
probabilities less than the chosen SIFT cutoff are predicted to
be deleterious and those that are greater than or equal to the SIFT
cutoff are predicted to be tolerated. Therefore, the accuracy for
predicting the phenotype that results from an amino acid
substitution based on sequence alignment of protein family
members has been assumed to be better than using a generalized
substitution scoring matrix [65].
Homology modeling and Structure validation
Homology modeling of Erg8, Erg9 and HFA1 protein products
was carried out using the Protein Model Portal (PMP) that
provides a single interface to access 12.7 million comparative
protein models across various protein structure databases (Release
date: 2010/03/19) and also provides interactive services for
template selection, target template alignment, model building and
quality assessment [66]. PMP is a module of the Protein Structure
Initiative Knowledge Base (PSI KB) developed by the Protein
Structure Bioinformatics group at the SIB - Swiss Institute of
Bioinformatics and the Biozentrum - University of Basel. The
overall model quality of structures obtained from homology
modeling were validated using ProSA-web Protein Structure
Analysis tool [67]. ProSA-web calculates the overall quality z-score
for a specific input structure and relates to the scores computed
from all experimental structures deposited in Protein Data Bank
(PDB). The z-score is displayed on a plot, so that low-resolution
structures and approximate models obtained through homology
modeling can be evaluated and compared against high resolution
structures.
Simulations for functional change in coding nsSNPs
based on 3D structures
Structural analysis was performed for evaluating the structural
stability of homology models for Erg8, Erg9 and HFA1 protein
products from both S. cerevisiae S288C and CEN.PK113-7D
strains. A measure of protein stability is the difference between the
free energies of the folded and infolded states. We used Eris, a
protein stability prediction server [68] that employs improved
Medusa force field [69] for estimation of change in free energy
difference (DDG) upon mutation. Eris features an all-atom force
filed, a fast side-chain packing algorithm, and a backbone
relaxation method for accurate protein stability predictions. To
obtain information about Accessible Surface Area (ASA) changes
caused by nsSNPs on protein structures, homology models of Erg8,
Erg9 and HFA1 protein products from both S. cerevisiae S288C and
CEN.PK113-7D were submitted to InterProPatch server [70] that
shows surface region differences.
Analysis of changes in Residue-Residue Interactions
caused by individual nsSNPs
Analysis of changes in residue-residue interactions caused by
nsSNPs on Erg8, Erg9 and HFA1 protein products was done at
University of Cambridge -UK, using Bongo server (Bonds ON
Graph). Bongo uses graph theoretic measures to annotate nsSNPs and
represent residue-residue interaction networks within proteins on
graphs. A single amino acid substitution encoded by a nsSNP may
often not only give rise to rearrangement of amino acid side chains
near the mutation site, but also to a substantial local or global
movement of polypeptide backbone. A major advantage of Bongo is
that it considers the long-distance structural impact of a point
mutation.
Structural analysis and Scanning of binding pockets
To analyze the overall structural differences between the Erg8,
Erg9 and HFA1 protein products of S. cerevisiae S288C and
CEN.PK113-7D, we used SuperPose, a sophisticated structural
superposition program that uniquely combines sequence align-
ment and difference distance (DD) matrix calculations to constrain
its quaternion superposition algorithm [71]. Through H-Predictor
server, we also analyzed putative hinge regions that are involved in
protein oligomerization via the domain-swapping mechanism
[72]. Using a simple contact-based potential for enthalpy and
graph theory- based estimation for entropy, H-Predictor quantifies
for each residue the propensity as the hinge region. Finally, the
binding pockets of Erg8, Erg9 and HFA1 protein products from
both S. cerevisiae S288C and CEN.PK113-7D were scanned using
Q-SiteFinder [73] to find out the protein-ligand binding site
differences caused by coding nsSNPs. The special feature of Q-
SiteFinder is that it uses interaction energy and a simple van der
Walls probe to locate energetically favourable binding sites. By
scanning binding pockets, not only the ligand binding sites of a
given protein can be identified, but also protein residues within a
suitable range of the binding pocket are identified, which could be
used for analysis of functional sites and comparison.
Strains and Media
The strains used in this study as well as the construction process
are shown in Figure 6. The plasmids (2micron multi-copy vectors)
pPK529 (Erg8), pPK532 (Erg9) and pPK534 (HFA1) were
transformed as single, double (in all combinations), and triple
over-expressions to the respective parental strains. The genes were
cloned between the TDH3 promoter and terminator region. In
addition, a gene (PSY) coding for a b-amyrin synthase from the
plant Pisum sativum (pea) [74] was transformed to the above
CEN.PK over-expression mutants and the reference strain
(CEN.PK-5D) using the commercially available pYES plasmid
(Invitrogen) as described previously [75]. The final strains
harbouring different combinations of plasmids and their designat-
ed names are shown in Figure 6. All the resulting strains were
prototrophic. Cultures were maintained by plating in SCD
medium and these stocks were used to inoculate the pre-cultures.
Pre-cultures were grown in shake flask cultures on defined mineral
medium [76], supplemented with vitamins, adjusted to pH 6.0 and
containing 2% (w/v) glucose.
Batch Cultivation Conditions
To determine the physiological characteristics of the different
yeast strains they were grown in batch cultivations in well-
controlled 2 L bioreactors with a working volume of 1.5 L. In
brief, the cultures were fed with a defined mineral medium as
described above, containing glucose (2% w/v) as the limited
nutrient. The bioreactors were equipped with two disc-turbine
impellers rotating at 600 rpm. The pH was kept constant at 5.0 by
addition of 2 M KOH or HCl and the temperature was
maintained at 30 uC. Air was used for sparging the bioreactor at
a constant flow rate of 1.0 vvm (volume of gas per volume of liquid
per minute).
Analysis of substrates and products
Cell dry weight was determined using nitrocellulose filters (pore
size 0.45 mm, Gelman Sciences). Fermentation samples were
immediately filtered and stored at 220 uC until analysis. The
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concentrations of glucose, ethanol, glycerol, acetate, succinate, and
pyruvate were determined by HPLC as described previously [77].
Sampling, extraction, determination and analysis of
ergosterol and b-amyrin
For the analysis of ergosterol and b-amyrin dublicate biological
samples were collected (30 ml), centrifuged at 4000 rpm for 3 min
and the pellets immediately stored at 220 uC. The defrosted pellet
was re-suspended in 2 ml 20% w/v sodium hydroxide in 50%
ethanol. The mixture was transferred to glass tube and was kept in
boiling water for 5 min with occasional shaking. Subsequently, 1
ml of 20% w/v sodium hydroxide in 50% ethanol and 2 ml
hexane were added, followed by vortex-mixing for 30–60 seconds.
The tubes were centrifuged for 5 min at 1000 rpm and the hexane
phase was extracted for further analysis. After drying the samples
were derivatised by adding 50 ml BSTFA and 50 ml pyridine [78],
dried and dissolved in 75 ml toluene.
GC-MS was used for quantifying the ergosterol and b-amyrin
content of the samples. The injection volume was 1 ml in a Rtx-
5 ms (30 meters, 0.25 mm ID) column with helium carrier. The
column temperature was maintained at 240 uC for 2 min, elevated
to (10 degrees/min) 330 uC and then held for 6.5 min at 330 uC.
Authentic b-amyrin and ergosterol were derivatized and analyzed
in GC-MS in the same manner.
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